Related references
Note: Only part of the references are listed.Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process
K. P. H. Mattos et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Polymyxin B Induced Generalized Hyperpigmentation in Neonates
Sunil Gothwal et al.
INDIAN JOURNAL OF PEDIATRICS (2016)
Histopathological findings of pigmented lesion and recovery of natural skin colour in a patient with polymyxin B-associated diffuse hyperpigmentation
Alexandre P. Zavascki et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Thien B. Tran et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Acquired skin hyperpigmentation following intravenous polymyxin B treatment: a cohort study
Karen P. H. Mattos et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Tigecycline Induced Hyperpigmentation of the Skin
S. J. Vandecasteele et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
Head and Neck Hyperpigmentation Probably Associated With Polymyxin B Therapy
Alexandre P. Zavascki et al.
ANNALS OF PHARMACOTHERAPY (2015)
The safety of polymyxin antibiotics
Theodoros Kelesidis et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Roger L. Nation et al.
LANCET INFECTIOUS DISEASES (2015)
Kojic acid-induced IL-6 production in human keratinocytes plays a role in its anti-melanogenic activity in skin
Hyunjung Choi et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
Diffuse cutaneous hyperpigmentation due to tigecycline or polymyxin B
Ryan C. Knueppel et al.
CLINICAL INFECTIOUS DISEASES (2007)
Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes
M Yoshida et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
